Advanced Solid, Malignant Tumors — Phase I Chinese PK
Citation(s)
An Open Label, Phase I, Rising Multiple Dose, Single Centre Study to Determine the PK and Tolerability of ZD6474 at Different Dose Levels in Chinese Patients With Solid Malignancy Tumor